---
title: "Top Artivion Executive Makes Notable Insider Move in Latest Stock Transaction"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298085808.md"
description: "Artivion (AORT) Senior Vice President Andrew M. Green sold 8,003 shares worth $216,295 on September 4, 2026. Despite Q2 revenue and EBITDA beating expectations and reaffirmed full-year guidance, the stock faces margin pressures from Endospan financing. TipRanks' AI Analyst Spark rates AORT as Neutral, citing high valuation (P/E 107.02) and volatile free cash flow, offset by steady revenue growth and strategic milestones like AMDS PMA approval."
datetime: "2026-09-05T02:10:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298085808.md)
  - [en](https://longbridge.com/en/news/298085808.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298085808.md)
generator: "portal-rs"
---

# Top Artivion Executive Makes Notable Insider Move in Latest Stock Transaction

New insider activity at Artivion ( (AORT) ) has taken place on September 4, 2026.

Andrew M. Green, Senior Vice President of Regulatory and Quality at Artivion, has sold 8,003 shares of Artivion stock in a transaction valued at $216,295, signaling a notable insider move in the company’s equity activity.

Artivion shares reacted to a stronger‑than‑expected Q2, with revenue and EBITDA beating consensus and management reaffirming full‑year guidance despite margin and cash‑flow pressure from Endospan financing and growth investments. Analysts’ recent price‑target tweaks stem mainly from updated revenue models using fresh 10‑Q data and recognition of strategic milestones like the Endospan acquisition, AMDS PMA approval, and accelerating stent graft and On‑X valve growth, which together support a more robust long‑term aortic portfolio even as near‑term profitability is constrained.

**Spark’s Take on AORT Stock**

According to Spark, TipRanks’ AI Analyst, AORT is a Neutral.

The score is primarily constrained by uneven financial quality—especially volatile and recently negative free cash flow—and a very high valuation (P/E 107.02). Offsetting these are steady revenue growth with strong gross margins and a constructive earnings-call outlook with reiterated 2026 guidance and key product/platform milestones, while technicals are only moderately supportive given the stock remains below longer-term moving averages.

To see Spark’s full report on AORT stock,  
 click here. 

**More about Artivion**

**YTD Price Performance:** -43.83%

**Average Trading Volume:** 736,123

**Technical Sentiment Signal:** Hold

**Current Market Cap:** $1.28B

### Related Stocks

- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)

## Related News & Research

- [Artivion SVP Regulatory and Quality Andrew M. Green disposes of USD 216,479 common shares](https://longbridge.com/en/news/298065550.md)
- [An NEA partner says not every AI task needs frontier intelligence](https://longbridge.com/en/news/298434703.md)
- [AI agents keep finding ways to bend the rules. Here are some of the wildest.](https://longbridge.com/en/news/298138114.md)
- [Anthropic's AI fluency chief says the best AI users know when to do the work themselves](https://longbridge.com/en/news/298433044.md)
- [YieldMax® AI & Tech Portfolio Option Income ETF declares $0.2888 dividend](https://longbridge.com/en/news/298334201.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**